| Fund ID | 805-4919346494 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 16% |
| Fund | Type | Gross assets |
|---|---|---|
| Sv Life Sciences Fund IV Cf, L.P. | Venture Capital | $412.1M |
| Sv Life Sciences Fund VI, L.P. | Venture Capital | $224.7M |
| Sv Life Sciences Fund V, L.P. | Venture Capital | $138.5M |
International Life Sciences Fund III Strategic Partners, L.P. reports $388,591 in gross assets, among the top 97% of private funds by size.
The stated minimum investment is $50,000.
International Life Sciences Fund III Strategic Partners, L.P. is managed by Sv Health Investors, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.